Evidence map›Paper›PMID 36384671›Full record

ArticleImmunity & ageing : I & A2022

The oldest unvaccinated Covid-19 survivors in South America.

Mateus V de Castro, Monize V R Silva, Michel S Naslavsky, Marilia O Scliar, Kelly Nunes, Maria Rita Passos-Bueno, Erick C Castelli, Jhosiene Y Magawa, Flávia L Adami, Ana I S Moretti and 15 more

Erratum issuedAbstract read
In one paragraph

Article in Immunity & ageing : I & A, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. The long-lived immune system of centenarians.Nature reviews. Immunology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors.

Mateus V de Castro *Human Genome and Stem Cell Research Center, University of São Paulo, São Paulo, São Paulo, Brazil.
Monize V R Silva *Human Genome and Stem Cell Research Center, University of São Paulo, São Paulo, São Paulo, Brazil.
Michel S NaslavskyHuman Genome and Stem Cell Research Center, University of São Paulo, São Paulo, São Paulo, Brazil.
Marilia O ScliarHuman Genome and Stem Cell Research Center, University of São Paulo, São Paulo, São Paulo, Brazil.
Kelly NunesHuman Genome and Stem Cell Research Center, University of São Paulo, São Paulo, São Paulo, Brazil.
Maria Rita Passos-BuenoHuman Genome and Stem Cell Research Center, University of São Paulo, São Paulo, São Paulo, Brazil.
Erick C Castelli *Department of Pathology, School of Medicine, UNESP - São Paulo State University, Botucatu, São Paulo, Brazil.
Jhosiene Y MagawaLaboratório de Imunologia, Instituto do Coração (InCor), LIM19, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, (HCFMUSP), São Paulo, Brazil.
Flávia L AdamiLaboratory of Antigen Targeting to Dendritic Cells, Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Ana I S MorettiLaboratório de Imunologia, Instituto do Coração (InCor), LIM19, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, (HCFMUSP), São Paulo, Brazil.
Vivian L de OliveiraLaboratório de Imunologia, Instituto do Coração (InCor), LIM19, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, (HCFMUSP), São Paulo, Brazil.
Silvia B BoscardinLaboratory of Antigen Targeting to Dendritic Cells, Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Edecio Cunha-NetoInstituto de Investigação em Imunologia-Instituto Nacional de Ciências e Tecnologia-iii-INCT, São Paulo, Brazil.
Jorge KalilLaboratório de Imunologia, Instituto do Coração (InCor), LIM19, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, (HCFMUSP), São Paulo, Brazil.
Emmanuelle JouanguyLaboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.
Paul BastardLaboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.
Jean-Laurent CasanovaImagine Institute, University of Paris, Paris, France.
Mauricio Quiñones-VegaProteomics Unit, Department of Biochemistry, Institute of Chemistry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Patricia Sosa-AcostaProteomics Unit, Department of Biochemistry, Institute of Chemistry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Jéssica de S GuedesProteomics Unit, Department of Biochemistry, Institute of Chemistry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Natália P de AlmeidaProteomics Unit, Department of Biochemistry, Institute of Chemistry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Fábio C S NogueiraProteomics Unit, Department of Biochemistry, Institute of Chemistry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Gilberto B DomontProteomics Unit, Department of Biochemistry, Institute of Chemistry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Keity S Santos *Laboratório de Imunologia, Instituto do Coração (InCor), LIM19, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, (HCFMUSP), São Paulo, Brazil.
Mayana ZatzHuman Genome and Stem Cell Research Center, University of São Paulo, São Paulo, São Paulo, Brazil. mayazatz@usp.br.

Funding

Theoretical Population Genetics SupplementR01GM075091 · NIGMS · UNIVERSITY OF WASHINGTON · PI WEIR, BRUCE S. · 2006 to 2020
$4.7M
NIGMS NIH HHS R01 GM075091
6 · The paper itself

Abstract

backgroundAlthough older adults are at a high risk of severe or critical Covid-19, there are many cases of unvaccinated centenarians who had a silent infection or recovered from mild or moderate Covid-19. We studied three Brazilian supercentenarians, older than 110 years, who survived Covid-19 in 2020 before being vaccinated.

resultsDespite their advanced age, humoral immune response analysis showed that these individuals displayed robust levels of IgG and neutralizing antibodies (NAbs) against SARS-CoV-2. Enrichment of plasma proteins and metabolites related to innate immune response and host defense was also observed. None presented autoantibodies (auto-Abs) to type I interferon (IFN). Furthermore, these supercentenarians do not carry rare variants in genes underlying the known inborn errors of immunity, including particular inborn errors of type I IFN.

conclusionThese observations suggest that their Covid-19 resilience might be a combination of their genetic background and their innate and adaptive immunity.

Indexed as

Covid-19ElderlySARS-CoV-2Supercentenarians

Identifiers

PMID36384671
PMCPMC9666972

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.